The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
The role of fibroblast activation protein in health and malignancy
Open accessAbstract
Fibroblast activation protein-α (FAP) is a type-II transmembrane serine protease expressed almost exclusively to pathological conditions including fibrosis, arthritis, and cancer. Across most cancer types, elevated FAP is associated with worse clinical outcomes. Despite the clear association between FAP and disease severity, the biological reasons underlying these clinical observations remain unclear. Here we review basic FAP biology and FAP’s role in non-oncologic and oncologic disease. We further explore how FAP may worsen clinical outcomes via its effects on extracellular matrix remodeling, intracellular signaling regulation, angiogenesis, epithelial-to-mesenchymal transition, and immunosuppression. Lastly, we discuss the potential to exploit FAP biology to improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134 · cited 1×
“The relatively unchanged levels of these cytokines after FAP ablation would suggest the latter [121].”
BackgroundTargeting cardiac fibrosis with engineered T cells
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1546-z · Cited by 801
Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2973 · Cited by 748
Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 748
Wang, L.-C. S., Lo, A., Scholler, J., Sun, J., Majumdar, R. S., Kapoor, V., Antzis, M., Cotner, C. E., Johnson, L. A., Durham, A. C., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0027 · Cited by 653
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffery, T., Ouellette, M. M., & Hollingsworth, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0291 · Cited by 519
Tran, E., Chinnasamy, D., Yu, Z., Morgan, R. A., Lee, C.-C. R., Restifo, N. P., & Rosenberg, S. A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130110 · Cited by 463
Scott, A. M., Wiseman, G., Welt, S., Adjei, A. A., Lee, F.-T., Hopkins, W., Divgi, C. R., Hanson, L. J., Mitchell, P., Gansen, D. N., et al. (2003) · PubMed · Cited by 438
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Puré, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38988 · Cited by 428
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 374
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Henry, L. R., Lee, H.-O., Lee, J. S., Klein-Szanto, A., Watts, P., Ross, E. A., Chen, W.-T., & Cheng, J. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1746 · Cited by 364
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Kakarla, S., Chow, K. K., Mata, M., Shaffer, D. R., Song, X.-T., Wu, M.-F., Liu, H., Wang, L. L., Rowley, D. R., Pfizenmaier, K., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.110 · Cited by 346
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Lee, H.-O., Mullins, S. R., Franco-Barraza, J., Valianou, M., Cukierman, E., & Cheng, J. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-245 · Cited by 304
DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis
Okondo, M. C., Johnson, D. C., Sridharan, R., Go, E. B., Chui, A. J., Wang, M. S., Poplawski, S. E., Wu, W., Liu, Y., Lai, J. H., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2229 · Cited by 290
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Mikheeva, S. A., Mikheev, A. M., Petit, A., Beyer, R., Oxford, R. G., Khorasani, L., Maxwell, J.-P., Glackin, C. A., Wakimoto, H., González-Herrero, I., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-194 · Cited by 289
Jansen, K., Heirbaut, L., Verkerk, R., Cheng, J. D., Joossens, J., Cos, P., Maes, L., Lambeir, A.-M., De Meester, I., Augustyns, K., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500031w · Cited by 287
Aertgeerts, K., Levin, I., Shi, L., Snell, G. P., Jennings, A., Prasad, G. S., Zhang, Y., Kraus, M. L., Salakian, S., Sridhar, V., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500092200 · Cited by 285
Prolyl peptidases: a serine protease subfamily with high potential for drug discovery
Rosenblum, J. S., & Kozarich, J. W. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00084-x · Cited by 284
Welt, S., Divgi, C. R., Scott, A. M., Garin-Chesa, P., Finn, R. D., Graham, M., Carswell, E. A., Cohen, A., Larson, S. M., & Old, L. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1193 · Cited by 266
Monsky, W. L., Lin, C., Aoyama, A., Kelly, T. J., Akiyama, S. K., Mueller, S. C., & Chen, W. T. (1994) · PubMed · Cited by 248
The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis.
Brown, D. D., Wang, Z., Furlow, J. D., Kanamori, A., Schwartzman, R. A., Remo, B. F., & Pinder, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1924 · Cited by 245
A Novel Protease-docking Function of Integrin at Invadopodia
Mueller, S. C., Ghersi, G., Akiyama, S. K., Sang, Q.-X. A., Howard, L., Pineiro-Sanchez, M., Nakahara, H., Yeh, Y., & Chen, W.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24947 · Cited by 244
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 243
Self-citationZhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242
Tillmanns, J., Hoffmann, D., Habbaba, Y., Schmitto, J. D., Sedding, D., Fraccarollo, D., Galuppo, P., & Bauersachs, J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.016 · Cited by 237
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Bauer, S., Jendro, M. C., Wadle, A., Kleber, S., Stenner, F., Dinser, R., Reich, A., Faccin, E., Gödde, S., Dinges, H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2080 · Cited by 230
Liu, F., Qi, L., Liu, B., Liu, J., Zhang, H., Che, D., Cao, J., Shen, J., Geng, J., Bi, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116683 · Cited by 227
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Self-citationSchuberth, P. C., Hagedorn, C., Jensen, S. M., Gulati, P., van den Broek, M., Mischo, A., Soltermann, A., Jüngel, A., Marroquin Belaunzaran, O., Stahel, R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-187 · Cited by 206
Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A.-L. A., & Puré, E. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.11.020 · Cited by 204
Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
Shi, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i8.840 · Cited by 199
Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis
Busso, N., Wagtmann, N., Herling, C., Chobaz-Péclat, V., Bischof-Delaloye, A., So, A., & Grouzmann, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62266-3 · Cited by 191
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
Lee, K. N., Jackson, K. W., Christiansen, V. J., Lee, C. S., Chun, J.-G., & McKee, P. A. (2006) · Blood · doi:10.1182/blood-2005-08-3452 · Cited by 190
Wang, H., Wu, Q., Liu, Z., Luo, X., Fan, Y., Liu, Y., Zhang, Y., Hua, S., Fu, Q., Zhao, M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.122 · Cited by 182
Advanced health biotechnologies in Thailand: redefining policy directions
Velasco, R. P., Chaikledkaew, U., Myint, C. Y., Khampang, R., Tantivess, S., & Teerawattananon, Y. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-1 · Cited by 182
Wikberg, M. L., Edin, S., Lundberg, I. V., Van Guelpen, B., Dahlin, A. M., Rutegård, J., Stenling, R., Öberg, Å., & Palmqvist, R. (2013) · Tumor Biology · doi:10.1007/s13277-012-0638-2 · Cited by 171
Brokopp, C. E., Schoenauer, R., Richards, P., Bauer, S., Lohmann, C., Emmert, M. Y., Weber, B., Winnik, S., Aikawa, E., Graves, K., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq519 · Cited by 166
Arnold, J. N., Magiera, L., Kraman, M., & Fearon, D. T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0150 · Cited by 166
Ghersi, G., Zhao, Q., Salamone, M., Yeh, Y., Zucker, S., & Chen, W.-T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1245 · Cited by 166
Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis
Aimes, R., Zijlstra, A., Hooper, J., Ogbourne, S., Sit, M.-L., Fuchs, S., Gotley, D., Quigley, J., & Antalis, T. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613388 · Cited by 163
Huber, M. A., Schubert, R. D., Peter, R. U., Kraut, N., Park, J. E., Rettig, W. J., & Garin-Chesa, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12035.x · Cited by 162
Wen, Y., Wang, C., Ma, T., Li, Z., Zhou, L., Mu, B., Leng, F., Shi, H., Li, Y., & Wei, Y. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01695.x · Cited by 162
Piñeiro-Sánchez, M. L., Goldstein, L. A., Dodt, J., Howard, L., Yeh, Y., & Chen, W.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7595 · Cited by 160
Lo, A., Li, C.-P., Buza, E. L., Blomberg, R., Govindaraju, P., Avery, D., Monslow, J., Hsiao, M., & Puré, E. (2017) · JCI Insight · doi:10.1172/jci.insight.92232 · Cited by 160
Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21
Dunshee, D. R., Bainbridge, T. W., Kljavin, N. M., Zavala-Solorio, J., Schroeder, A. C., Chan, R., Corpuz, R., Wong, M., Zhou, W., Deshmukh, G., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710582 · Cited by 158
Levy, M. T., McCaughan, G. W., Marinos, G., & Gorrell, M. D. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01503.x · Cited by 154
Molecular cloning of seprase: a serine integral membrane protease from human melanoma
Goldstein, L. A., Ghersi, G., Piñeiro-Sánchez, M. L., Salamone, M., Yeh, Y., Flessate, D., & Chen, W. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00032-x · Cited by 150
Keane, F. M., Yao, T., Seelk, S., Gall, M. G., Chowdhury, S., Poplawski, S. E., Lai, J. H.-S., Li, Y., Wu, W., Farrell, P., et al. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.12.001 · Cited by 142
Ariga, N., Sato, E., Ohuchi, N., Nagura, H., & Ohtani, H. (2001) · International Journal of Cancer · Cited by 139
Christiansen, V. J., Jackson, K. W., Lee, K. N., & McKee, P. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.11.006 · Cited by 137
Fan, M.-H., Zhu, Q., Li, H., Ra, H.-J., Majumdar, S., Gulick, D. L., Jerome, J. A., Madsen, D. H., Christofidou‐Solomidou, M., Speicher, D. W., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701433 · Cited by 134
Aoyama, A., & Chen, W. T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8296 · Cited by 133
Keane, F. M., Nadvi, N. A., Yao, T., & Gorrell, M. D. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08051.x · Cited by 130
Chen, H., Yang, W., Wen, Q.-T., Xu, L., & Chen, M. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.09.001 · Cited by 128
A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion
Lee, K. N., Jackson, K. W., Christiansen, V. J., Chung, K. H., & McKee, P. A. (2004) · Blood · doi:10.1182/blood-2003-12-4240 · Cited by 126
A Mechanism for Regulation of Melanoma Invasion
Nakahara, H., Nomizu, M., Akiyama, S. K., Yamada, Y., Yeh, Y., & Chen, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27221 · Cited by 126
Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
Zhen, E. Y., Jin, Z., Ackermann, B. L., Thomas, M. K., & Gutierrez, J. A. (2016) · Biochemical Journal · doi:10.1042/bj20151085 · Cited by 123 · cited 3×
“Given the recent discovery that FAP cleaves and inactivates the hormone FGF21 [20, 71], the role of FAP in metabolic diseases has just started to be investigated.”
BackgroundKawase, T., Yasui, Y., Nishina, S., Hara, Y., Yanatori, I., Tomiyama, Y., Nakashima, Y., Yoshida, K., Kishi, F., Nakamura, M., et al. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0340-0 · Cited by 121
Huang, Y., Simms, A. E., Mazur, A., Wang, S., León, N. R., Jones, B. N., Aziz, N., & Kelly, T. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9392-x · Cited by 120
Chen, L., Qiu, X., Wang, X., & He, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.039 · Cited by 120
Molecular Characterization of Human Breast Tumor Vascular Cells
Bhati, R. S., Patterson, C., Livasy, C., Fan, C., Ketelsen, D., Hu, Z., Reynolds, E. R., Tanner, C., Moore, D., Gabrielli, F., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070988 · Cited by 119
Targeted Disruption of Mouse Fibroblast Activation Protein
Niedermeyer, J., Kriz, M., Hilberg, F., Garin‐Chesa, P., Bamberger, U., Lenter, M., Park, J., Viertel, B., Püschner, H., Mauz, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1089-1094.2000 · Cited by 119
Fibroblast activation protein: Purification, epitope mapping and induction by growth factors
Rettig, W. J., Su, S. L., Fortunato, S. R., Scanlan, M. J., Raj, B. K. M., Garin‐Chesa, P., Healey, J. H., & Old, L. J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580314 · Cited by 118
FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor
Ramirez‐Montagut, T., Blachère, N. E., Sviderskaya, E. V., Bennett, D. C., Rettig, W. J., Garin‐Chesa, P., & Houghton, A. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207730 · Cited by 117
Rettig, W. J., Chesa, P. G., Beresford, H. R., Feickert, H. J., Jennings, M. T., Cohen, J., Oettgen, H. F., & Old, L. J. (1986) · PubMed · Cited by 116
Laverman, P., van der Geest, T., Terry, S. Y. A., Gerrits, D., Walgreen, B., Helsen, M. M. A., Nayak, T. K., Freimoser–Grundschober, A., Waldhauer, I., Hosse, R. J., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.152959 · Cited by 109
Li, M., Li, M., Yin, T., Shi, H., WEN, Y., Zhang, B., Chen, M., Xu, G., Ren, K., & Wei, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4868 · Cited by 108
Edosada, C. Y., Quan, C. L., Tran, T., Pham, V. C., Wiesmann, C., Fairbrother, W. J., & Wolf, B. B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.087 · Cited by 106
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas
Yue, D., Li, H., Che, J., Zhang, Y., Tseng, H.-H. K., Jin, J. Q., Luh, T. M., Leprieur, E. G., Mo, M., Zheng, Q., et al. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-34 · Cited by 106
Fischer, E., Chaitanya, K., Wüest, T., Wadle, A., Scott, A. M., van den Broek, M. F., Schibli, R., Bauer, S., & Renner, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0644 · Cited by 104
Ariga, N., Sato, E., Ohuchi, N., Nagura, H., & Ohtani, H. (2001) · International Journal of Cancer · Cited by 101
Wen, X., He, X., Jiao, F., Wang, C., Sun, Y., Ren, X., & Li, Q. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14768383625385 · Cited by 100
Kahounová, Z., Kurfürstová, D., Bouchal, J., Kharaishvili, G., Navrátil, J., Remšík, J., Šimečková, Š., Študent, V., Kozubík, A., & Souček, K. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23101 · Cited by 98
Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents
Chen, M., Lei, X., Shi, C., Huang, M., Li, X., Wu, B., Li, Z., Han, W., Du, B., Hu, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94258 · Cited by 98
Iwasa, S., Okada, K., Chen, W., Jin, X., Yamane, T., Ooi, A., & Mitsumata, M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.030 · Cited by 97
Gong, C., Nie, Y., Qu, S., Liao, J.-Y., Cui, X., Yao, H., Zeng, Y., Su, F., Song, E., & Liu, Q. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0125 · Cited by 97
Aggarwal, S., Brennen, W. N., Kole, T. P., Schneider, E., Topaloglu, Ö., Yates, M. S., Cotter, R. J., & Denmeade, S. R. (2007) · Biochemistry · doi:10.1021/bi701921b · Cited by 96
Milner, J. M., Kevorkian, L., Young, D. A., Jones, D., Wait, R., Donell, S. T., Barksby, E., Patterson, A. M., Middleton, J., Cravatt, B. F., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1877 · Cited by 93
Chung, K., Hsu, S., Chu, Y.-R., Lin, M.-Y., Jiaang, W.-T., Chen, R., & Chen, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088772 · Cited by 92
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
Eager, R., Cunningham, C. C., Senzer, N. N., Richards, D., Raju, R. N., Jones, B. N., Uprichard, M. J., & Nemunaitis, J. J. (2009) · Clinical Oncology · doi:10.1016/j.clon.2009.04.007 · Cited by 92
Lai, D., MA, L., & Wang, F. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1475 · Cited by 92
Expression of the fibroblast activation protein during mouse embryo development
Niedermeyer, J., Garin‐Chesa, P., Kriz, M., Hilberg, F., Mueller, E., Bamberger, U., Rettig, W. J., & Schnapp, A. (2001) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11330865 · Cited by 92
Bušek, P., Balážiová, E., Matrasová, I., Hilser, M., Tomáš, R., Syrůček, M., Zemanová, Z., Krepela, E., Běláček, J., & Šedo, A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5274-9 · Cited by 92
Niedermeyer, J., Scanlan, M. J., Garin‐Chesa, P., Daiber, C., Fiebig, H., Old, L. J., Rettig, W. J., & Schnapp, A. (1997) · International Journal of Cancer · Cited by 91
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
Eager, R. M., Cunningham, C. C., Senzer, N. N., Stephenson, J., Anthony, S. P., O'Day, S. J., Frenette, G., Pavlick, A. C., Jones, B. N., Uprichard, M. J., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-263 · Cited by 91
Artym, V. V. (2002) · Carcinogenesis · doi:10.1093/carcin/23.10.1593 · Cited by 91
Egger, C., Cannet, C., Gérard, C., Suply, T., Ksiazek, I., Jarman, E., & Beckmann, N. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.022 · Cited by 91
Park, S. Y., Kim, H. M., & Koo, J. S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3291-9 · Cited by 90
Neuropeptide Y A Novel Mechanism for Ischemic Angiogenesis
Żukowska, Z., Grant, D. S., & Lee, E. W. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00232-3 · Cited by 85
Kelly, T., Kechelava, S., Rozypal, T. L., et al. (1998) · PubMed · Cited by 83
Jia, J., Martin, T. A., Ye, L., & Jiang, W. G. (2014) · BMC Cell Biology · doi:10.1186/1471-2121-15-16 · Cited by 82
Fibroblast activation protein (FAP) as a novel metabolic target
Sanchez-Garrido, M. A., Habegger, K. M., Clemmensen, C., Holleman, C. L., Müller, T. D., Pérez–Tilve, D., Li, P., Agrawal, A., Finan, B., Drucker, D. J., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.07.003 · Cited by 82
Ospelt, C., Mertens, J. C., Jüngel, A., Brentano, F., Maciejewska-Rodrigues, H., Huber, L., Hemmatazad, H., Wüest, T., Knuth, A. K., Gay, R. E., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27395 · Cited by 81
Spegarova, J. S., Krepela, E., Mareš, V., Trim, J. E., Dbalý, V., Marek, J., Vaníčková, Z., Lisá, V., Yea, C., & Šedo, A. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.785 · Cited by 78
Mentlein, R., Hattermann, K., Hemion, C., Jungbluth, A. A., & Held‐Feindt, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.119 · Cited by 78
Park, C. K., Jung, W. H., & Koo, J. S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3929-2 · Cited by 77
Mathew, S., Scanlan, M. J., Raj, B. K. M., Murty, V. V. V. S., Garin‐Chesa, P., Old, L. J., Rettig, W. J., & Chaganti, R. S. K. (1995) · Genomics · doi:10.1016/0888-7543(95)80157-h · Cited by 76
The Expression of a Type II Transmembrane Serine Protease (Seprase) in Human Gastric Carcinoma
Mori, Y., Kono, K., Matsumoto, Y., et al. (2004) · Oncology · doi:10.1159/000082926 · Cited by 74
Dienus, K., Bayat, A., Gilmore, B., & Seifert, O. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1084-x · Cited by 73
Gulati, P., Rühl, J., Kannan, A., Pircher, M., Schuberth, P., Nytko, K. J., Pruschy, M. N., Sulser, S., Haefner, M., Jensen, S. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1788 · Cited by 73
Purification, identification and characterisation of seprase from bovine serum
Collins, P. J., McMahon, G. P., O’Brien, P., & O’Connor, B. F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.006 · Cited by 71
Mouse fibroblast‐activation protein
Niedermeyer, J., Enenkel, B., Park, J. E., Lenter, M., Rettig, W. J., Damm, K., & Schnapp, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540650.x · Cited by 69
Chen, M., Xiang, R., Wen, Y., Xu, G., Wang, C., Luo, S., Yin, T., Wei, X., Shao, B., Liu, N., et al. (2015) · Scientific Reports · doi:10.1038/srep14421 · Cited by 69
The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Park, H., Lee, Y., Lee, H., Kim, J.-W., Hwang, J., Kim, J., Yoon, Y., Han, H., & Kim, H. (2017) · Tumor Biology · doi:10.1177/1010428317718403 · Cited by 67
Christiansen, V. J., Jackson, K. W., Lee, K. N., Downs, T., & McKee, P. A. (2013) · Neoplasia · doi:10.1593/neo.121850 · Cited by 61
Gottschalk, S. M., Feng, Y., Ji, M., Kakarla, S., & Song, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082658 · Cited by 61
Yang, W., Han, W., Ye, S., Liu, D., Wu, J., Liu, H., Li, C., & Chen, H. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.06.007 · Cited by 60
Kilvaer, T. K., Rakaee, M., Hellevik, T., Östman, A., Strell, C., Bremnes, R. M., Busund, L., Dønnem, T., & Martínez-Zubiaurre, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192157 · Cited by 60
Fibroblast activation protein expression in Crohnʼs disease strictures
Rovedatti, L., Sabatino, A. D., Knowles, C. H., Sengupta, N., Biancheri, P., Corazza, G. R., & MacDonald, T. T. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21446 · Cited by 59
Ge, Y., Zhan, F., Barlogie, B., Epstein, J., Shaughnessy, J. D., & Yaccoby, S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05976.x · Cited by 57
Walsh, M. P., Duncan, B. B., Larabee, S. M., Krauss, A. C., Davis, J. P. E., Cui, Y., Kim, S. Y., Guimond, M., Bachovchin, W. W., & Fry, T. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058860 · Cited by 56
Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma
Ghobadi, A. (2018) · Current Research in Translational Medicine · doi:10.1016/j.retram.2018.03.005 · Cited by 55
Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma
Hua, X., Yu, L., Huang, X., Liao, Z., & Xian, Q. (2011) · Diagnostic Pathology · doi:10.1186/1746-1596-6-111 · Cited by 54
Goodman, J. D., Rozypal, T. L., & Kelly, T. J. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025493605850 · Cited by 51
Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer
Jung, Y. Y., Lee, Y. K., & Koo, J. S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3594-9 · Cited by 50
Gao, L., Wang, F., Zheng, Y., Fu, Z., Zheng, L., & Chen, L. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0359-3 · Cited by 50
Tanswell, P., Garin‐Chesa, P., Rettig, W. J., Welt, S., Divgi, C. R., Casper, E. S., Finn, R. D., Larson, S. M., Old, L. J., & Scott, A. M. (2001) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2001.01335.x · Cited by 49
Hornig, N., Kermer, V., Frey, K., Diebolder, P., Kontermann, R. E., & Müller, D. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182594387 · Cited by 48
Wäldele, S., Wunrau, C., Beckmann, D., Korb‐Pap, A., Wehmeyer, C., Pap, T., & Dankbar, B. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0524-6 · Cited by 48
Jia, J., Martin, T. A., Ye, L., Meng, L., Xia, N. L., Jiang, W. G., & Zhang, X. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3224 · Cited by 48
Okada, K., Chen, W., Iwasa, S., Jin, X., Yamane, T., Ooi, A., & Mitsumata, M. (2003) · Oncology · doi:10.1159/000074650 · Cited by 47
Sun, S., Albright, C. F., Fish, B., George, H. J., Selling, B. H., Hollis, G. F., & Wynn, R. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1572 · Cited by 47
Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma
Zhang, M., Xu, L., Wang, X., Sun, B., & Ding, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3151 · Cited by 45
Increased N‐terminal cleavage of alpha‐2‐antiplasmin in patients with liver cirrhosis
de Willige, S. U., Malfliet, J. J. M. C., Janssen, H. L. A., Leebeek, F. W. G., & Rijken, D. C. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12396 · Cited by 45
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11729 · Cited by 45
Chen, W., Ye, L., Wen, D., & Chen, F. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0305-4 · Cited by 43
Dong, R., Guo, J., Zhang, Z., Zhou, Y., & Hua, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.193 · Cited by 43
Kennedy, A., Dong, H., Chen, D., & Chen, W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23871 · Cited by 41
Williams, K., de Ribeiro, A. J. V., Prakoso, E., Veillard, A.-S., Shackel, N. A., Bu, Y., Brooks, B. A., Cavanagh, E., Raleigh, J., McLennan, S. V., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.024 · Cited by 41
Tillmanns, J., Widera, C., Habbaba, Y., Galuppo, P., Kempf, T., Wollert, K. C., & Bauersachs, J. K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.061 · Cited by 39
Schmidt, A., Müller, D., Mersmann, M., Wüest, T., Gerlach, E., Garin‐Chesa, P., Rettig, W. J., Pfizenmaier, K., & Moosmayer, D. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02046.x · Cited by 39
Hu, M., Qian, C., Hu, Z., Fei, B., & Zhou, H. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0159 · Cited by 39
Identification and characterization of the promoter of fibroblast activation protein
Cheng, J. D. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e175 · Cited by 37
Wüest, T., Moosmayer, D., & Pfizenmaier, K. (2001) · Journal of Biotechnology · doi:10.1016/s0168-1656(01)00355-8 · Cited by 37
Identification of an Alternatively Spliced Seprase mRNA That Encodes a Novel Intracellular Isoform
Goldstein, L. A., & Chen, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2554 · Cited by 34
Seifert, O. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1002 · Cited by 33
de Willige, S. U., Keane, F. M., Bowen, D. G., Malfliet, J. J. M. C., Zhang, H. E., Maneck, B., McCaughan, G. W., Leebeek, F. W. G., Rijken, D. C., & Gorrell, M. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178987 · Cited by 32
Expression of seprase in effusions from patients with epithelial ovarian carcinoma
Zhang, M., Qiao, Y., Nesland, J. M., & Suo, Z. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200704020-00010 · Cited by 31
Huang, C., Suen, C., Lin, C., Chien, C., Lee, H.-Y., Chung, K., Tsai, T., Jiaang, W.-T., Hwang, M., & Chen, X. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr017 · Cited by 31
The analysis of complex developmental programmes: amphibian metamorphosis
Kanamori, A., & Brown, D. D. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.d01-251.x · Cited by 28
Pennisi, A., Li, X., Ling, W., Khan, S., Gaddy, D., Suva, L. J., Barlogie, B., Shaughnessy, J. D., Aziz, N., & Yaccoby, S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07696.x · Cited by 28
Tillmanns, J., Fraccarollo, D., Galuppo, P., Wollert, K. C., & Bauersachs, J. K. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.037 · Cited by 28
Lv, B., Xie, F., Zhao, P., Ma, X., Jiang, W. G., Yu, J. Q., Zhang, X., & Jia, J. (2016) · PubMed · Cited by 24
A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy
Wang, J., Li, Q., Li, X., Yuan, W., Huang, S., Cai, S., & Xu, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.016 · Cited by 24
Yang, L., Ma, L., & Lai, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt095 · Cited by 23
Zhang, J., Valianou, M., Simmons, H. H., Robinson, M. K., Lee, H., Mullins, S., Marasco, W. A., Adams, G. P., Weiner, L. M., & Cheng, J. D. (2012) · The FASEB Journal · doi:10.1096/fj.12-210377 · Cited by 22
Self-citationMatrasová, I., Bušek, P., Balážiová, E., & Šedo, A. (2017) · Biomedical Papers · doi:10.5507/bp.2017.010 · Cited by 20
Li, W., Yang, L., Wei, F., Chen, Y., Jing, T., Ma, L., Liu, B., Li, Y., Shaoxia, W., Fu, Q., et al. (2015) · Biotechnology Letters · doi:10.1007/s10529-015-1855-8 · Cited by 15
Huang, S., Zhang, Y., Zhong, J., Pan, Y., Cai, S., & Xu, J. H. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000593 · Cited by 15
Yu, H., Yang, J., Li, Y., & Jiao, S. (2015) · PubMed · Cited by 8
Cited by
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Li, H., Kim, H., Xu, F., Han, J., Yao, Q., Wang, J., Pu, K., Peng, X., & Yoon, J. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00307k · Cited by 509
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Rurik, J. G., Aghajanian, H., & Epstein, J. A. (2021) · Circulation Research · doi:10.1161/circresaha.121.318005 · Cited by 265
Kaur, G., Muthumalage, T., & Rahman, I. (2023) · Aging Cell · doi:10.1111/acel.13850 · Cited by 53
Xu, Z., Sinha, A., Pandya, D. N., Schnicker, N. J., & Wadas, T. J. (2025) · RSC Chemical Biology · doi:10.1039/d4cb00267a · Cited by 5
Metadata
- Authors
- Fitzgerald, A. A., & Weiner, L. M.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2020-06-29
- Volume
- 39
- Issue
- 3
- Pages
- 783-803
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W3038979222
- Cited by
- 589
- References
- 156
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.